IL1B and cancer: In systemic inflammatory diseases and cancer, NLRP3 inflammasome activation drives proteolytic cleavage of pro-caspase-1, enabling maturation and secretion of IL-1β and IL-18, potent pro-inflammatory cytokines that amplify innate immunity and promote systemic inflammation [83].